COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED SEPTEMBER 30 2022
(Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015)
I, Dhaval Soni, Company Secretary and Compliance Officer, have examined the following compliance requirement of Zydus Lifesciences Limited (Company) and certify that the Company has maintained a Structured Digital Database (SDD) pursuant to provisions of Regulation 3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations):
Sr. | Compliance Requirement | Yes / | Observation/ Remark |
No | No | ||
1. | Whether the Company has a Structured Digital Database in | Yes | |
place? | |||
2. | Whether control exists as to who can access the SDD for read | Yes | |
/ write alongwith the names and PAN of such person? | |||
3. | Whether all the UPSI had been captured in the Database. If not | Yes | |
details of events that had not been captured and the reason | |||
for the same? | |||
4. | Whether the recipients were upfront informed that the | Yes | |
information which they will be receiving shortly is UPSI and the | |||
entry has been captured in the Database prior to forwarding | |||
the UPSI data. If not details of events that have not been | |||
captured and the reason for the same? | |||
5. | Whether nature of UPSI have been captured alongwith date | Yes | |
and time? | |||
6. | Whether name of persons who have shared the information | Yes | |
has been captured along with PAN or any other identifier? | |||
7. | Whether name of persons with whom information is shared | Yes | |
has been captured along with PAN or any other identifier? | |||
8. | Whether the database has been maintained internally? | Yes | |
9. | Whether audit trail is maintained? | Yes | |
10. | Whether time stamping is maintained? | Yes | |
11. | Whether the database is non-tamperable? | Yes | |
12. | Any other measures to ensure non-tamperability of the | No | Not required. |
Database? | |||
Note: The information of the audit should cover the period when such information was inserted in the SDD upto the date of disclosure.
The number of days for which non-compliance was observed: Not Applicable
Further, I also confirm that the Company was required to capture 1 number of event during the quarter ended on September 30, 2022 and has captured 1 number of the said required event.
For, Zydus Lifesciences Limited
DHAVAL NARENDRA SONI
Digitally signed by DHAVAL NARENDRA SONI
Date: 2022.10.07 09:35:03 +05'30'
Dhaval N. Soni
Company Secretary & Compliance Officer
Date | : | October 7, 2022 |
Place | : | Ahmedabad |
